◆ 会议时间：2024年3月8-10日
◆ 会议地点：日本 神户

◆ 会议简介：

2024年第88届日本循环器学会(JCS)年度科学会议将于2024年3月8-10日在日本神户举行。JCS年会是世界上最大的单一国家心脏病学会议之一，每年有超过15000人参加。

日本循环器学会(JCS)是日本及至世界上最负盛名的心血管疾病专业医学学会之一，现拥有超过26000名成员。JCS有着80多年的悠久历史，1935年日本临床心血管病学杂志创刊，1936年日本临床心血管病学会成立，1953年学会和期刊更名日本循环器学会（期刊）。JCS的业务范围广泛，包括发行期刊、制定指南和组织科学会议。JCS年度科学会议有约20,000名参与者。JCS还与AHA，ACC，ESC，韩国心脏病学会（KSC）和中国心脏病学会（CSC）等国外心脏病学会联合举办研讨会，并与亚洲国家相关组织宣合作开展临床试验和研究。未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

第88回日本循環器学会学術集会（JCS2023）
The 88th Annual Scientific Meeting of the Japanese Circulation Society (JCS2023)

会期/Date：
March 8（Fri.）-10（Sun.）, 2024

会場/Venue：
Kobe Convention Center
Kobe Portopia Hotel
Kobe International Exhibition Hall
Kobe International Conference Center

テーマ/Theme：
The Future of Cardiology
-Challenges in Overcoming Cardiovascular Disease-

摘要征文投稿-Call for Abstracts：

Plenary Sessions and Symposia

Abstract Submission Starts: (Thu.), July 6, 2023
Abstract Submission Deadline: (Wed.), August 9, 2023

Regular Abstracts and Case Reports

Abstract Submission Starts: (Thu.), July 6, 2023
Abstract Submission Deadline: (Wed.), September 20, 2023

Late Breaking (Clinical Trials / Cohort Studies)

Abstract Submission Starts: (Tue.), August 1, 2023
Abstract Submission Deadline: (Fri.), September 22, 2023

点此提交摘要>>>Submit Abstract>>>

Message from the Congress Chairperson

The 88th Annual Scientific Meeting of the Japanese Circulation Society (JCS) will be held over the three days from Friday, March 8 to Sunday, March 10, 2024 at the Kobe International Conference Center, Kobe International Exhibition Hall, and Kobe Portopia Hotel. This is the 88th year since the JCS was established in 1936, since when it has grown massively and now numbers over 27,000 regular members. It is a great honor for me to be appointed President of an Annual Meeting with such a history.

The Annual Meeting is a highly significant occasion at which a large number of members can gather together, gain knowledge of cardiology, and boost their networking. Since 2019, however, the impact of COVID-19 has required that it be held mostly online, as well as necessitating many changes and reductions in scale, and this has been a major hindrance both for networking between members and for opportunities for young doctors to present their work. As it now seems that COVID-19 is finally being vanquished, with its categorization under the Infectious Disease Control Law revised and infection prevention measures relaxed, we are going ahead with preparations for this Annual Meeting in Kobe to enable face-to-face presentations and lively discussion.

That said, post-COVID society is not the same as it was pre-COVID. Not only is Japan continuing to have an increasingly low birthrate and a higher proportion of older people, meaning that the disease structure of the population has greatly changed, but we have also now learned that the ways of life and the lives themselves of its residents can be threatened by an unanticipated disease such as COVID-19. Accordingly, in this Annual Meeting my intention is that we should not merely revert to our pre-COVID status, but rather make this an opportunity to go back to the origin of the Annual Meeting and link this to the future of cardiology, and the chosen theme is “The Future of Cardiology: Challenges in Overcoming Cardiovascular Disease.”Specifically, while emphasizing opportunities for presentations by the doctors, medical staff, and researchers who will take responsibility for cardiology in future, we are also considering augmenting the general oral presentations and moderated poster sessions, among others. We will also press ahead with cooperation with the government and private companies in order to advance the Stroke and Cardiovascular Disease Control Act and the Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease, and intend to hold events for patients and the general public. We are further considering events with an emphasis on collaboration with other disciplines including physical science, engineering, and pharmacy.

Professor Joseph C. Wu (Stanford University School of Medicine, USA) has been invited to give the Mikamo Lecture, and Dr. Hitoshi Nakagama (President, National Cancer Center, Tokyo) to give the Mashimo Memorial Lecture.

I hope that JCS members will join me in March 2024 in Kobe, rising to the challenge of overcoming cardiovascular disease and linking this to the future of cardiology through the lively discussion and active networking that are the hallmarks of our Annual Meeting. I am very much looking forward to meeting you all in person.

Ken-ichi Hirata MD, PhD, FJCS, FESC
Congress Chairperson of the 88th Annual Scientific Meeting of the Japanese Circulation Society (JCS2024)
Professor, Department of Internal Medicine,
Division of Cardiovascular Medicine,
Kobe University Graduate School of Medicine
(President of the Japanese Circulation Society)

注册费：

Registration Fee

(JPY)

* A certificate is required for exchange students. The Certificate form can be downloaded from the below.
Please fill in the form and upload the form onto the Japanese Registration system.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。